Please assess the completion status of the following clinical trial:

Trial Title: Blood Products Transfusion in Cardiac Surgery After the Implementation of a Coagulation Monitoring System at Patient Bedside: Thromboelastometry Versus Standard Transfusion Protocol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients~* over 18 years~* undergoing cardiac surgery~* with cardiopulmonary bypass~* bleed excessively~As it is not possible to predict in advance who will bleed, informed consent will be required for all patients over 18 who are to undergo cardiac surgery with CPB.~Will be randomized to either group~1. Those patients with diffuse bleeding after protamine administration. and / or~2. They bleed excessively after surgery. Are excessive bleeding criteria: the debit ≥ 300ml drains in the first hour; ≥ 250ml in the second hour or ≥ 150ml at any later time. Consider that the patient is bleeding excessively when the drains debit is \<150ml.~Exclusion Criteria:~* Patients \<18 years~* Extracorporeal circulation surgery~* Surgery with Mini extracorporeal circulation (MECC)~* Refuse to participate in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group C (Type: ACTIVE_COMPARATOR): • conventional protocol, volume replacement with massive bleeding.
- Group ROTEM (Type: EXPERIMENTAL): • Protocol according to the different tests to be performed with thromboelastography

Based on this trial design, predict the completion outcome and termination type (if applicable).